Filtered By:
Specialty: Cardiology
Drug: Clopidogrel
Therapy: Thrombolytic Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Independent Predictors of Major Adverse Events following Coronary Stenting over 28 Months of Follow-Up
Conclusions: Background diabetes mellitus, prior thrombolytic therapy, PAI-1 and vWF prestenting activity may be useful for MACE prediction over 28 months of follow-up.Cardiology 2015;132:176-181
Source: Cardiology - August 11, 2015 Category: Cardiology Source Type: research
